Wells Fargo
TRIB

Wells Fargo’s Trinity Biotech TRIB Stock Holding History

Wells Fargo’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$972 Hold
83
– – ﹤0.01% 6462
2026
Q1 		$1.36K Buy
+83
New +$1.83K ﹤0.01% 6300
2022
Q2 		– Sell
-6
Closed -$1K – 7501
2022
Q1 		$1K Hold
6
– – ﹤0.01% 6868
2021
Q4 		$1K Hold
6
– – ﹤0.01% 7079
2021
Q3 		$2K Hold
6
– – ﹤0.01% 6596
2021
Q2 		$2K Hold
6
– – ﹤0.01% 6565
2021
Q1 		$3K Hold
6
– – ﹤0.01% 6599
2020
Q4 		$3K Hold
6
– – ﹤0.01% 6241
2020
Q3 		$2K Hold
6
– – ﹤0.01% 6149
2020
Q2 		$2K Hold
6
– – ﹤0.01% 6114
2020
Q1 		$1K Hold
6
– – ﹤0.01% 6087
2019
Q4 		$1K Hold
6
– – ﹤0.01% 6274
2019
Q3 		$1K Buy
+6
New +$1.56K ﹤0.01% 6299
2017
Q3 		– Sell
-1
Closed – – 6469
2017
Q2 		$0 Hold
1
– – ﹤0.01% 6453
2017
Q1 		$0 Hold
1
– – ﹤0.01% 6502
2016
Q4 		$1K Hold
1
– – ﹤0.01% 6180
2016
Q3 		$1K Sell
1
-59
-98% -$110K ﹤0.01% 6123
2016
Q2 		$102K Sell
60
-5
-8% -$8.45K ﹤0.01% 4822
2016
Q1 		$114K Sell
65
-6
-8% -$9.55K ﹤0.01% 4745
2015
Q4 		$125K Sell
71
-137
-66% -$243K ﹤0.01% 4759
2015
Q3 		$357K Sell
208
-5
-2% -$12.1K ﹤0.01% 4158
2015
Q2 		$578K Buy
213
+17
+9% +$44.2K ﹤0.01% 3987
2015
Q1 		$567K Buy
196
+11
+6% +$30.5K ﹤0.01% 3868
2014
Q4 		$484K Sell
185
-30
-14% -$77.6K ﹤0.01% 3967
2014
Q3 		$588K Sell
215
-89
-29% -$289K ﹤0.01% 3799
2014
Q2 		$1.05M Buy
304
+53
+21% +$188K ﹤0.01% 3483
2014
Q1 		$913K Buy
251
+5
+2% +$19.7K ﹤0.01% 3562
2013
Q4 		$928K Buy
246
+14
+6% +$50.4K ﹤0.01% 3461
2013
Q3 		$757K Buy
232
+46
+25% +$135K ﹤0.01% 3522
2013
Q2 		$470K Buy
+186
New +$463K ﹤0.01% 3720

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's TRIB Position: Q2 2026 in Review

Wells Fargo held its Trinity Biotech (TRIB) position steady in Q2 2026 at 83 shares worth $972. The position accounts for ﹤0.01% of the portfolio, ranked #6462.

Wells Fargo first reported a position in TRIB in Q2 2013 and has held it in 30 quarters since. The position peaked at $1.05M in Q2 2014. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Wells Fargo held 83 shares of Trinity Biotech worth $972 as of Q2 2026.
  • Wells Fargo left its Trinity Biotech share count unchanged in Q2 2026.
  • Trinity Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6462 holding.
  • Wells Fargo first reported a position in Trinity Biotech in Q2 2013 and has held it in 30 quarters since.
  • Wells Fargo's Trinity Biotech position peaked at $1.05M in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.